BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 29453475)

  • 1. Basal Cell Carcinoma in Cases with or without Xeroderma Pigmentosum.
    Ghartimagar D; Ghosh A; Shrestha SR; Shrestha S; Thapa S; Narasimhan R; Talwar OP
    JNMA J Nepal Med Assoc; 2017; 56(208):432-7. PubMed ID: 29453475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin tumors in xeroderma pigmentosum: Evaluation of a large series and a literature review.
    Baykal C; Atcı T; Yılmaz Z; Büyükbabani N
    J Cutan Pathol; 2021 Jul; 48(7):884-895. PubMed ID: 33569789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xeroderma pigmentosum. A clinical study of 24 Libyan cases.
    Khatri ML; Shafi M; Mashina A
    J Am Acad Dermatol; 1992 Jan; 26(1):75-8. PubMed ID: 1732340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superficial basal cell carcinoma: A comparison of superficial only subtype with superficial combined with other subtypes by age, sex and anatomic site in 3150 cases.
    Pyne JH; Myint E; Barr EM; Clark SP; David M; Na R; Hou R
    J Cutan Pathol; 2017 Aug; 44(8):677-683. PubMed ID: 28493477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular and Periocular Tumors in Xeroderma Pigmentosum: A Study of 120 Asian Indian Patients.
    Kaliki S; Jajapuram SD; Maniar A; Mishra DK
    Am J Ophthalmol; 2019 Feb; 198():146-153. PubMed ID: 30336128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Clinical Study of Basal Cell Carcinoma.
    Kasumagic-Halilovic E; Hasic M; Ovcina-Kurtovic N
    Med Arch; 2019 Dec; 73(6):394-398. PubMed ID: 32082007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in age and topographic distribution of the different histological subtypes of basal cell carcinoma, Taubaté (SP), Brazil.
    Ferreira FR; Pevide Bda C; Rodrigues RF; Nascimento LF; Lira ML
    An Bras Dermatol; 2013; 88(5):726-30. PubMed ID: 24173177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basosquamous carcinoma and melanoma collision tumor in a child with xeroderma pigmentosum.
    Bostanci S; Akay BN; Kirmizi A; Okcu Heper A; Farabi B
    Pediatr Dermatol; 2020 Mar; 37(2):390-392. PubMed ID: 31957124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two unusual tumors in a patient with xeroderma pigmentosum: atypical fibroxanthoma and basosquamous carcinoma.
    Youssef N; Vabres P; Buisson T; Brousse N; Fraitag S
    J Cutan Pathol; 1999 Oct; 26(9):430-5. PubMed ID: 10563498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum.
    Grampurohit VU; Dinesh US; Rao R
    J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of skin cancer in xeroderma pigmentosum.
    Kraemer KH; DiGiovanna JJ; Peck GL
    J Dermatol; 1992 Nov; 19(11):715-8. PubMed ID: 1293159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Xeroderma pigmentosum: report of 6 cases in Dakar].
    Dieng MT; Niang SO; Dangou JM; Ndiaye B
    Bull Cancer; 2001 Feb; 88(2):199-202. PubMed ID: 11257594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum at a tertiary care center in Saudi Arabia.
    Alwatban L; Binamer Y
    Ann Saudi Med; 2017; 37(3):240-244. PubMed ID: 28578364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of vismodegib for the treatment of multiple basal cell carcinomas in a patient with xeroderma pigmentosum.
    Soura E; Plaka M; Dessinioti C; Chasapi V; Stefanaki C; Antoniou C; Stratigos A
    Pediatr Dermatol; 2018 Nov; 35(6):e334-e336. PubMed ID: 30178564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.
    Kraemer KH; Lee MM; Andrews AD; Lambert WC
    Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinase-13 and Ki-67 in nonmelanoma skin cancer in xeroderma pigmentosum and non-xeroderma pigmentosum.
    El-Hawary AK; Yassin E; Khater A; Abdelgaber S
    Am J Dermatopathol; 2013 Feb; 35(1):45-9. PubMed ID: 22722466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of histological subtypes of basal cell carcinoma with age, sex and distribution of skin lesions: a five-year study at Ramathibodi Hospital.
    Puavilai S; Sirapan S
    J Med Assoc Thai; 2002 May; 85(5):560-4. PubMed ID: 12188385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma pigmentosum.
    Zeligman I; Lutzner MA; Scott CI
    Birth Defects Orig Artic Ser; 1971 Jun; 7(8):296-7. PubMed ID: 5173292
    [No Abstract]   [Full Text] [Related]  

  • 20. Vismodegib Therapy for Basal Cell Carcinoma in an 8-Year-Old Chinese Boy with Xeroderma Pigmentosum.
    Fife D; Laitinen MA; Myers DJ; Landsteiner PB
    Pediatr Dermatol; 2017 Mar; 34(2):163-165. PubMed ID: 28297142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.